Toxoplasma gondii: A potential role in the genesis of psychiatric disorders.

G Fond, D Capdevielle, A Macgregor, J Attal… - L' …, 2012 - inserm.hal.science
INTRODUCTION: Toxoplasma gondii is the most common protozoan parasite in developed
nations. Up to 43% of the French population may be infected, depending on eating habits …

The efficacy and safety of low frequency repetitive transcranial magnetic stimulation for treatment-resistant depression: the results from a large multicenter French RCT

J Brunelin, I Jalenques, B Trojak, J Attal, D Szekely… - Brain stimulation, 2014 - Elsevier
Context The aim of this study was to assess whether the combination of low frequency repetitive
transcranial magnetic stimulation (rTMS) and venlafaxine (150–225 mg/day) is effective …

Mirror self-face perception in individuals with schizophrenia: Feelings of strangeness associated with one's own image

…, D Capdevielle, R Altman, A Macgregor, J Attal… - Psychiatry …, 2017 - Elsevier
Self-face recognition is crucial for sense of identity and for maintaining a coherent sense of
self. Most of our daily life experiences with the image of our own face happen when we look …

[HTML][HTML] Social motor coordination in unaffected relatives of schizophrenia patients: a potential intermediate phenotype

…, JP Boulenger, MC Gély-Nargeot, J Attal… - Frontiers in behavioral …, 2013 - frontiersin.org
Intermediate endophenotypes emerge as an important concept in the study of schizophrenia.
Although research on phenotypes mainly investigated cognitive, metabolic or …

A Lack of Clinical Effect of High‐frequency r TMS to Dorsolateral Prefrontal Cortex on Bulimic Symptoms: A Randomised, Double‐blind Trial

…, I Jaussent, T Sigaud, S Billard, J Attal… - European Eating …, 2016 - Wiley Online Library
Studies suggest that stimulation of the left dorsolateral prefrontal cortex (DLPFC) reduces
food craving in bulimic patients, but evidence supporting repetitive transcranial magnetic …

[HTML][HTML] Attitudes towards vaccines, intent to vaccinate and the relationship with COVID-19 vaccination rates in individuals with schizophrenia

S Raffard, S Bayard, M Eisenblaetter, J Attal, C Andrieu… - Vaccines, 2022 - mdpi.com
Schizophrenia patients are at high risk of developing severe COVID-19 outcomes but recent
evidence suggests that they are under-vaccinated. This study explored the role of potential …

[HTML][HTML] Diminished capacity to make treatment decision for COVID-19 vaccination in schizophrenia

…, S Bayard, M Eisenblaetter, P Tattard, J Attal… - European Archives of …, 2023 - Springer
Recent evidence suggests that people with schizophrenia are at high risk for severe COVID-19
and should be prioritized for vaccination. However, impaired decision-making capacities …

Mood disorders: When should we use repetitive transcranial magnetic stimulation?

…, T Bougerol, G Dall'Igna, J Attal… - … (Paris, France: 1983), 2019 - europepmc.org
17. Centre hospitalier Esquirol, unité de recherche et de neurostimulation, 87000 Limoges,
France; Centre hospitalier Esquirol, pôle universitaire de psychiatrie de l'adulte et de la …

[HTML][HTML] Examining transcranial random noise stimulation as an add-on treatment for persistent symptoms in schizophrenia (STIM'Zo): a study protocol for a multicentre …

J Brunelin, M Mondino, J Haesebaert, J Attal, M Benoit… - Trials, 2021 - Springer
Background One out of three patients with schizophrenia failed to respond adequately to
antipsychotics and continue to experience debilitating symptoms such as auditory …

[HTML][HTML] The Patient, Investigator, Nurse, Carer Questionnaire (PINC-Q): a cross-sectional, retrospective, non-interventional study exploring the impact of less frequent …

K Pungor, P Sanchez, S Pappa, J Attal, K Leopold… - BMC psychiatry, 2021 - Springer
Background To understand the implications of switching from paliperidone palmitate 1-monthly
(PP1M) to paliperidone palmitate 3-monthly (PP3M) treatment of schizophrenia from the …